Mark Ferguson
About
In The Last Decade
Mark Ferguson
15 papers receiving 538 citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 271
- Cancer Research 177
- Organic Chemistry 135
- Physiology 80
- Endocrine and Autonomic Systems 70
Countries citing papers authored by Mark Ferguson
This map shows the geographic impact of Mark Ferguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ferguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ferguson more than expected).
Fields of papers citing papers by Mark Ferguson
This network shows the impact of papers produced by Mark Ferguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ferguson. The network helps show where Mark Ferguson may publish in the future.
Co-authorship network of co-authors of Mark Ferguson
This figure shows the co-authorship network connecting the top 25 collaborators of Mark Ferguson. A scholar is included among the top collaborators of Mark Ferguson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Ferguson. Mark Ferguson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Phase I/IIa Clinical Trial of Human Embryonic Stem Cell (hESC)-Derived Retinal Pigmented Epithelium (RPE, OpRegen) Transplantation in Advanced Dry Form Age-Related Macular Degeneration (AMD): Interim Results | 14 |
| 2 | 1 | |
| 3 | 8 | |
| 4 | 165 | |
| 5 | 107 | |
| 6 | 101 | |
| 7 | A potential role for Periostin in Barrett’s carcinogenesis | 0 |
| 8 | 3 | |
| 9 | 25 | |
| 10 | 4 | |
| 11 | 3 | |
| 12 | 9 | |
| 13 | 12 | |
| 14 | 82 | |
| 15 | 1 | |
| 16 | 24 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.